retatrutide phase 2 nejm weight loss 48 weeks This week's most cited articles: 1. Original Article: Triple–Hormone-Receptor Agonist for Obesity — A Trial https://t.co/jNL1GNnHPT #Endocrinology Retatrutide Dosage for Weight Loss

Following additional studies, the FDA also approved their use for weight loss in 2014

Todays medications (Ozempic, Wegovy, Mounjaro, etc.) all trace their conceptual roots back to this discovery

Get Retatrutide (R-30) Ascension Peptides Where to Buy Retatrutide: See our complete guide to trusted retatrutide vendors what to look for, current pricing, and red flags to avoid

& Gause-Nilsson, I

Medicare historically did not cover weight-loss-only indications, but the 2026 GLP-1 Bridge program allows Medicare patients $50/month access to Foundayo through December 2026

Many providers recommend holding the weekly injection during acute gastrointestinal illness and resuming at the current dose once symptoms resolve